Dog Myasthenia Gravis: Recognition and Care

Myasthenia gravis is an immune-mediated neuromuscular disease in dogs causing profound muscle weakness and aspiration pneumonia risk, requiring urgent management.

Key Facts

Myasthenia gravis involves autoantibodies destroying acetylcholine receptors at the neuromuscular junction
Acquired focal MG presents as megaesophagus with regurgitation as the primary sign
Generalized MG causes exercise-induced weakness that improves with rest
Aspiration pneumonia is the leading cause of death in dogs with megaesophagus from MG
Many dogs achieve spontaneous remission after 6-18 months of treatment

Welfare Considerations

Dogs with myasthenia gravis experience significant functional impairment and welfare compromise from weakness and regurgitation. Megaesophagus causes food to pool in a dilated esophagus and regurgitate, threatening aspiration pneumonia with every meal. Feeding affected dogs in an upright position - maintained for 10-15 minutes after each meal - dramatically reduces aspiration risk but requires dedicated owner commitment. The prospect of spontaneous remission motivates continued supportive care through what can be a prolonged and demanding management period.

What You Can Do

Feed dogs with megaesophagus from MG in an upright seated position using a Bailey chair
Provide small frequent meals of appropriate food texture to minimize aspiration risk
Monitor for aspiration pneumonia signs including coughing, fever, and respiratory distress
Administer pyridostigmine as prescribed to improve neuromuscular transmission
Monitor acetylcholine receptor antibody titers to track remission progress